- Home
- ALBT vs NLSP Comparison
ALBT vs NLSP Comparison
Compare ALBT & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALBT
- NLSP
- Stock Information
- Founded
- ALBT 2014
- NLSP 2015
- Country
- ALBT United States
- NLSP Switzerland
- Employees
- ALBT N/A
- NLSP N/A
- Industry
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- ALBT Health Care
- NLSP Health Care
- Exchange
- ALBT Nasdaq
- NLSP Nasdaq
- Market Cap
- ALBT 7.9M
- NLSP 6.9M
- IPO Year
- ALBT N/A
- NLSP 2021
- Fundamental
- Price
- ALBT $4.90
- NLSP $1.51
- Analyst Decision
- ALBT
- NLSP
- Analyst Count
- ALBT 0
- NLSP 0
- Target Price
- ALBT N/A
- NLSP N/A
- AVG Volume (30 Days)
- ALBT 99.4K
- NLSP 30.0K
- Earning Date
- ALBT 04-14-2025
- NLSP 05-14-2025
- Dividend Yield
- ALBT N/A
- NLSP N/A
- EPS Growth
- ALBT N/A
- NLSP N/A
- EPS
- ALBT N/A
- NLSP N/A
- Revenue
- ALBT N/A
- NLSP N/A
- Revenue This Year
- ALBT N/A
- NLSP N/A
- Revenue Next Year
- ALBT N/A
- NLSP N/A
- P/E Ratio
- ALBT N/A
- NLSP N/A
- Revenue Growth
- ALBT N/A
- NLSP N/A
- 52 Week Low
- ALBT $2.11
- NLSP $1.30
- 52 Week High
- ALBT $21.60
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- ALBT 43.81
- NLSP 43.78
- Support Level
- ALBT $5.18
- NLSP $1.30
- Resistance Level
- ALBT $7.89
- NLSP $1.60
- Average True Range (ATR)
- ALBT 0.64
- NLSP 0.10
- MACD
- ALBT -0.20
- NLSP 0.01
- Stochastic Oscillator
- ALBT 12.48
- NLSP 62.86
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.